Skip to main content
. 2023 Sep 4;2(1):e000372. doi: 10.1136/bmjmed-2022-000372

Figure 1.

Figure 1

Shifting pattern of management of type 2 diabetes. HbA1c=haemoglobin A1c; ASCVD=atherosclerotic cardiovascular disease; CKD=chronic kidney disease; HF=heart failure; GIP=glucose dependent insulinotropic polypeptide; GLP1RA=glucagon-like peptide 1 receptor agonist; SGLT2i=sodium glucose cotransporter 2 inhibitor; SU=sulfonylurea; DPP4i=dipeptidyl peptidase 4 inhibitor. *Insulin is preferred for acute management of severe hyperglycaemia; †Thiazolidinediones improve insulin resistance